Literature DB >> 2247091

The mechanism of activation of the alternative pathway of complement by cell-bound C4b.

T C Farries1, K L Steuer, J P Atkinson.   

Abstract

Investigations into the mechanism of alternative pathway-dependent lysis of C4b-coated cells are reported. Test cells (EAC1q4b) were formed by reaction of sheep erythrocytes with antibody, C1 and C4. In C5-deficient serum, more C3b was deposited onto EAC1qC4b than onto control cells (EAC1q). The possibility that the C4bBb enzyme could form was considered, but no C3 convertase activity was generated when magnesium, properdin and factors B and D were added to EAC1qC4b. Binding studies employing radiolabeled components provided evidence that C4b bound the C3 convertase, C3bBbP, through a weak interaction with C3b. These data implied C3 conversion would be localized to the cell surface, thereby amplifying C3b deposition. This could be demonstrated in vitro. C3b, properdin, factor B and factor D were all required and the amplified C3b deposition was not due to deposition onto C4b itself. In serum, C5 convertase activity would be consequently expressed and cell lysis would result. This could be the mechanism by which the sera of C2-deficient patients mediate lysis of antibody coated sheep erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2247091     DOI: 10.1016/0161-5890(90)90104-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Analysis of human C4A and C4B binding to an immune complex in serum.

Authors:  B D Reilly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Authors:  M Harboe; G Ulvund; L Vien; M Fung; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

3.  Bypassing complement: evolutionary lessons and future implications.

Authors:  John P Atkinson; Michael M Frank
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Key Components of the Complement Lectin Pathway Are Not Only Required for the Development of Inflammatory Arthritis but Also Regulate the Transcription of Factor D.

Authors:  V Michael Holers; Anna Borodovsky; Robert I Scheinman; Nhu Ho; Joseline Ramos Ramirez; József Dobó; Péter Gál; Jared Lindenberger; Annette G Hansen; Dhruv Desai; Rasmus Pihl; Steffen Thiel; Nirmal K Banda
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

Review 5.  Complement C4, Infections, and Autoimmune Diseases.

Authors:  Hongbin Wang; Mengyao Liu
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.